Get started

Live Feed

Delayed 3m

Press · Buys

Signed out · 3-min delay · Sign up for real-time

Updates arrive automatically.

  • FF EAI Robotics Ecosystem (FFR) CEO YT Jia Shares Weekly Investor Update: Recaps FFR's Listing Closing and First Investor Day in New York; FFR Sold and Shipped 351 Robot Devices in October, Setting Another Monthly Record
    PR·

    FF EAI Robotics Ecosystem (FFR) CEO YT Jia Shares Weekly Investor Update: Recaps FFR's Listing Closing and First Investor Day in New York; FFR Sold and Shipped 351 Robot Devices in October, Setting Another Monthly Record

    FF EAI Robotics Ecosystem Inc. ("FFR") (NASDAQ:FFR), has officially listed on the U.S. stock market as the first pure-play Four-Core Full-Stack AI humanoid and bionic robotics company.FFR sold and shipped 351 devices in October, setting another monthly record. Since the Company began sales and deliveries at the end of February, cumulative sales and shipments have reached 1,168 units, topping 1,000 for the first time, and continuing to deliver at a positive gross margin.FFR and FFAI's New York regional operations are now up and running and are now officially recruiting business partners. The first phase covers New York, New Jersey, Massachusetts, southwestern Connecticut, and eastern Pennsylv

    $FFR
  • Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: FFR Sold and Shipped 351 Robot Devices in October, Setting Another Monthly Record and Bringing Cumulative Sales and Shipments to 1,168 Units
    PR·

    Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: FFR Sold and Shipped 351 Robot Devices in October, Setting Another Monthly Record and Bringing Cumulative Sales and Shipments to 1,168 Units

    FF EAI Robotics Ecosystem Inc. ("FFR") (NASDAQ:FFR), has officially listed on the U.S. stock market as the first pure-play Four-Core Full-Stack AI humanoid and bionic robotics company. FFR sold and shipped 351 devices in October, setting another monthly record. Since the Company began sales and deliveries at the end of February, cumulative sales and shipments have reached 1,168 units, topping 1,000 for the first time, and continuing to deliver at a positive gross margin. FFR and FFAI’s New York regional operations are now up and running and is now officially recruiting business partners. The first phase covers New York, New Jersey, Massachusetts, southwestern Connecticut, and eastern

    $FFAI$FFR
  • HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan
    PR·

    HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan

    — Follows US FDA new drug application submission in September 2026, marking important global regulatory progress — — Filings supported by positive SAFFRON global Phase III data demonstrating statistically significant and clinically meaningful PFS and OS improvements — — Data selected for ESMO 2026 Presidential Symposium and simultaneously published in The New England Journal of Medicine —

    $HCM
  • Mesoblast Board Changes
    PR·

    Mesoblast Board Changes

    Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced rotational changes and retirement of certain members of its Board, and reiterated its intention to add new members with the requisite global commercial experience in the biopharmaceutical sector in line with its next phase of commercial delivery and growth. After 12 years of serving on the Board since 2014, Mr William Burns will retire from the Board at the Company’s 2026 Annual General Meeting. Ms Jane Bell AM will take over as Chair of the Nomination and Remuneration Committee, having been co-Chair with Mr Burns

    $MESO
  • Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System
    PR·

    Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System

    SonicForce is an investigational coronary intravascular lithotripsy (IVL) system that uses acoustic pressure waves, similar to those used to break up kidney stones, to crack calcium in coronary arteries and restore blood flowThe system is designed to bring purposeful innovation to treating complex coronary calcium, with longer treatment lengths, more pulses and enhanced catheter deliverabilityApproval of the investigational system would further strengthen Abbott's comprehensive coronary devices portfolio, complementing its advanced imaging, lesion preparation and stent technologies

    $ABT
  • Anteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026
    PR·

    Anteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026

    Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)) a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced 30-day clinical and hemodynamic outcomes for the Medium-size DurAVR® Transcatheter Heart Valve (THV) in twenty-two severe aortic stenosis patients with medium aortic annuli (aortic annulus area 492 ± 38 mm2). The DurAVR THV demonstrated single digit mean gradients, large effective orifice areas (EOAs), no moderate or severe paravalvular leaks and no valve related mortality,

    $AVR
  • TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients
    PR·

    TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients

    Late-Breaking P4 study, simultaneously published in NEJM, shows CT guidance delivers matched one-year clinical outcomes with shorter procedures, demonstrating pre-procedural CCTA can guide key PCI planning decisions NAVIGATE-PCI shows Heartflow PCI Navigator drove modifications to stent length and lesion prep compared to angiography alone

    $HTFL
  • GE HealthCare debuts Allia Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imaging
    PR·

    GE HealthCare debuts Allia Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imaging

    Extra-wide-bore, cable-less ceiling gantry and real-time digital twin aim to keep cases moving, regardless of procedure type or patient size AI-powered precision imaging designed to automatically balance image quality and radiation dose in real time across 2D and 3D imaging Designed to work with the GE HealthCare clinical applications and compatible third-party technologies care teams already rely on, with the flexibility to support future solutions Predictive service support through OnWatch Predict, a deep learning-based technology designed to help minimize clinical operations disruptions for a reliable patient schedule GE HealthCare (NASDAQ:GEHC) today introduced Allia™ Celeo

    $GEHC
  • Affle to acquire Perion, to scale its CPCU business across Developed markets
    PR·

    Affle to acquire Perion, to scale its CPCU business across Developed markets

    Perion shareholders to receive US$ 11.70 per shareThe deal values Perion at an implied Equity value of ~US$ 420 millionCombined business strengthens AI-powered consumer conversions, expands global scale, delivers measurable ROI for advertisers and sustained long-term value creation

    $PERI
  • BMO Completes Acquisition of Euroz Hartleys Capital Markets Business, Strengthening its Leading Global Metals and Mining Franchise
    PR·

    BMO Completes Acquisition of Euroz Hartleys Capital Markets Business, Strengthening its Leading Global Metals and Mining Franchise

    BMO Financial Group (TSX:BMO) (NYSE:BMO) today announced the completion of its acquisition of the Australian capital markets business of Euroz Hartleys Group Limited (ASX: EZL), strengthening its leading global metals and mining franchise and expanding BMO Capital Markets' presence in Australia. The acquisition combines BMO's global investment banking and distribution capabilities with Euroz Hartleys' deep Australian expertise in equities research, institutional sales and trading, equity capital markets, mergers and acquisitions, and strategic advisory. The combined platform connects clients more directly with capital, investors and opportu

    $BMO
  • Venture Global Commences Commercial Operations of Phase One of Plaquemines LNG
    PR·

    Venture Global Commences Commercial Operations of Phase One of Plaquemines LNG

    COD declared just over 53 months from FID on Phase One First long-term sales and purchase agreement (SPA) cargo lifted by Shell On October 31, 2026, Venture Global (NYSE:VG) commenced commercial operations of the first phase of its second LNG export project – Plaquemines LNG – and the sale of low-cost, U.S. LNG to the first phase’s long-term customers. The commercial operations date (COD) for Phase 1 of Plaquemines LNG was reached in just over 53 months from the final investment decision on the project, making it among the fastest greenfield LNG projects ever completed. "Achieving commercial operations at the first phase of our second LNG project in 53 months is a testament to our

    $VG
  • Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study Results
    PR·

    Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study Results

    Analyses presented at TCT highlight how patient selection, timely Impella support and consistent care protocols may help improve outcomes during and after complex heart procedures Johnson & Johnson announced results from three clinical analyses being presented during the Transcatheter Cardiovascular Therapeutics annual scientific symposium (TCT 2026) that report positive survival and patient outcomes data when Impella™ heart pumps are used to support a patient’s heart during and after high-risk percutaneous coronary intervention (HRPCI). Real-world and observational registry data from 1,379 HRPCI patients across hospitals in the U.S. and Europe show lower in-hospital cardiovascular mortal

    $JNJ
  • Perion Enters into Definitive Merger Agreement with Affle
    PR·

    Perion Enters into Definitive Merger Agreement with Affle

    All-cash price of $11.70 per share, a 34.5% premium to Perion’s closing share price on October 30, 2026 Perion ("Perion" or the "Company") (NASDAQ & TASE: PERI), an advanced technology leader solving for the complexities of digital advertising through AI-native execution infrastructure, and Affle 3iL Ltd., a subsidiary of Affle International Pte. Ltd. ("Affle"), a global technology company delivering AI-led solutions in mobile advertising, today announced that they entered into a definitive agreement under which Affle will acquire the Company in an all-cash transaction. Upon closing of the transaction, Perion will become a wholly-owned subsidiary of Affle, and will continue to operate und

    $PERI
  • TotalEnergies Strengthens Cooperation with PETRONAS SONANGOL and OIL INDIA LIMITED to Reduce Methane Emissions
    PR·

    TotalEnergies Strengthens Cooperation with PETRONAS SONANGOL and OIL INDIA LIMITED to Reduce Methane Emissions

    On the occasion of the meeting of the Oil and Gas Decarbonization Charter (OGDC) member companies in Abu Dhabi, TotalEnergies highlights its cooperation with National Oil & Gas Companies to reduce methane emissions, through its partnerships with PETRONAS in Malaysia, SONANGOL in Angola and Oil India Limited (OIL) in India. Developing a Methane Technology Evaluation Center with PETRONAS in Southeast Asia TotalEnergies signed a collaboration agreement with PETRONAS, the Japan Organization for Metals and Energy Security (JOGMEC) and JGC Corporation to contribute to the development of SEA METEC (Southeast Asia Methane Emissions Technology Evaluation Center). Led by PETRONAS, SEA METEC will

    $TTE
  • "Together, Together" for Final Show: The Garden Honors Harry Styles Sold-Out 30 Night Run
    PR·

    "Together, Together" for Final Show: The Garden Honors Harry Styles Sold-Out 30 Night Run

    New York Knicks Captain & 2026 Finals MVP Jalen Brunson Presented Banner To Styles During Final Residency Show At The World’s Most Famous Arena MEDIA DOWNLOADS: APPROVED PHOTOS + VIDEOS (FREE FOR USE) HERE Madison Square Garden Entertainment Corp. (NYSE: MSGE) ("MSG Entertainment") celebrated the final show of Harry Styles’ sold-out 30-night "Together, Together" residency at MSG tonight by raising a banner to The Garden’s rafters and unveiling a new "Defining Moments" exhibit at the arena. During tonight’s final show of the unprecedented 30-night run, and less than two weeks after their own banner was raised to The Garden’s rafters, New York Knicks Captain and 2026 Finals MVP Jalen Brun

    $MSGE
  • NIO Inc. Provides October 2026 Delivery Update
    PR·

    NIO Inc. Provides October 2026 Delivery Update

    34,246 vehicles were delivered in October 2026334,547 vehicles were delivered year-to-date in 2026, increasing by 38.5% year-over-yearCumulative deliveries reached 1,332,139 as of October 31, 2026

    $NIO
  • XPENG Announces Vehicle Delivery Results for October 2026
    PR·

    XPENG Announces Vehicle Delivery Results for October 2026

    XPeng Inc. ((", XPENG", or the ", Company, ", NYSE:XPEV), a leading global Physical AI company, today announced its vehicle delivery results for October 2026. XPENG achieved a new monthly record with total deliveries of 50,237 vehicles in October, up 22% month-over-month and 20% year-over-year. Overseas deliveries also reached an all-time monthly high of 13,326 units, up 166% year-over-year. In October 2026, the XPENG L05 was officially launched in the Chinese mainland, with deliveries set to begin on November 1, 2026. On October 26, 2026, XPENG obtained a demonstration operation license to conduct Level 4 Robotaxi services in Guangzhou. The appr

    $XPEV
  • Li Auto Inc. October 2026 Delivery Update
    PR·

    Li Auto Inc. October 2026 Delivery Update

    Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China’s new energy vehicle market, today announced that it delivered 29,025 vehicles in October 2026. As of October 31, 2026, Li Auto’s cumulative deliveries reached 1,862,676. In October, Li Auto delivered over 3,000 units of the new Li MEGA. The Company also introduced its proprietary Lianshan Battery and Lianshan Motor, along with the Lianshan Battery Warranty Program. The 2026 Li i6, launched on October 28, is equipped with the Lianshan Battery, the MACH M100 chip, and more than 20 additional upgrades in intelligence and configuration, enhancing its range,

    $LI